5-Fluorouracil combined with cisplatin via arterial induction for advanced T-stage nasopharyngeal carcinoma: A 10-year outcome of a phase I/II study

BACKGROUND AND PURPOSE: Currently, there is no optimal dose recommendation for a 120-h continuous infusion of 5-fluorouracil via arterial cannulation for advanced T-stage nasopharyngeal carcinoma (NPC). Thus, the aim of this study was to determine the maximum tolerated dose (MDT), along with the eff...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiang, Li, Zheng, Yun, Ren, PeiRong, Lin, Sheng, Zhang, JianWen, Wen, QingLian, He, LiJia, Shang, ChangLing, Wu, JingBo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9364084/
https://www.ncbi.nlm.nih.gov/pubmed/35965592
http://dx.doi.org/10.3389/fonc.2022.868070

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9364084/
https://www.ncbi.nlm.nih.gov/pubmed/35965592
http://dx.doi.org/10.3389/fonc.2022.868070

Ejemplares similares